Consensus Accolade, Inc.

Equities

ACCD

US00437E1029

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-01 pm EDT			5-day change	1st Jan Change
7.36 ^USD	-3.54%		-21.70%	-38.72%

Apr. 30	Wells Fargo Cuts Price Target on Accolade to $10 From $12, Maintains Equalweight Rating	MT
Apr. 26	Morgan Stanley Trims Accolade's Price Target to $12 From $13, Maintains Equal Weight Rating	MT

Evolution of the average Target Price on Accolade, Inc.

Price target over the last 5 years

History of analyst recommendation changes

6644d6eb2dae023356d9ecc431583858.X616zpXIHL-YmvHEzvaxEDEM4Y6Tdqsp5ZeMJEX9hWA.KOY3oNiJc4nW9cmzp4z1XktKmOe-AM4ejce-EgPItw42wAKm5PtDjevWlg~4e25d95b8666457c3ec4e826a230920d

Analyst Recommendations on Accolade, Inc.

Wells Fargo Cuts Price Target on Accolade to $10 From $12, Maintains Equalweight Rating	Apr. 30	MT
Morgan Stanley Trims Accolade's Price Target to $12 From $13, Maintains Equal Weight Rating	Apr. 26	MT
Stifel Adjusts Accolade's Price Target to $13 From $15, Keeps Buy Rating	Apr. 22	MT
Leerink Partners Initiates Accolade at Outperform Rating With $16 Price Target	Feb. 26	MT
Raymond James Adjusts Accolade's Price Target to $16 From $12, Keeps Outperform Rating	Jan. 09	MT
Stifel Cuts Accolade's Price Target to $15 From $17, Keeps Buy Rating	Jan. 04	MT
Piper Sandler Adjusts Accolade's Price Target to $12 From $15, Maintains Overweight Rating	Nov. 22	MT
Canaccord Genuity Adjusts Accolade Price Target to $17 From $18, Maintains Buy Rating	23-10-05	MT
Truist Securities Adjusts Price Target on Accolade to $15 From $17, Keeps Buy Rating	23-10-05	MT
Raymond James Adjusts Price Target on Accolade to $12 From $15, Keeps Outperform Rating	23-10-05	MT
Stifel Adjusts Price Target on Accolade to $17 From $15, Maintains Buy Rating	23-06-30	MT
Wells Fargo Adjusts Price Target on Accolade to $14 From $13, Maintains Equalweight Rating	23-06-30	MT
Credit Suisse Adjusts Accolade's Price Target to $15 From $13, Keeps Neutral Rating	23-06-30	MT
Needham Raises Price Target on Accolade to $17 From $15, Maintains Buy Rating	23-06-30	MT
BofA Upgrades Accolade to Buy From Neutral, Price Target is $16.50	23-05-24	MT
DA Davidson Raises Accolade's Price Target to $16 From $14, Keeps Buy Rating	23-05-01	MT
Guggenheim Adjusts Accolade's Price Target to $18 From $16, Keeps Buy Rating	23-04-28	MT
Canaccord Genuity Adjusts Price Target on Accolade to $18 From $14, Maintains Buy Rating	23-04-28	MT
Morgan Stanley Adjusts Accolade's Price Target to $14 From $11, Keeps Equalweight Rating	23-04-28	MT
Credit Suisse Raises Accolade's Price Target to $13 From $11, Notes Elevated Expectations into Fiscal Q4 Keeps Neutral Rating	23-04-25	MT
Wells Fargo Adjusts Price Target on Accolade to $13 From $10, Maintains Equalweight Rating	23-04-21	MT
Stephens Initiates Accolade at Overweight With $18 Price Target	23-04-12	MT
Guggenheim Upgrades Accolade to Buy From Neutral, Price Target is $16	23-03-23	MT
Jefferies Downgrades Accolade to Hold From Buy, Price Target is $14	23-02-09	MT
Raymond James Starts Accolade at Outperform With $15 Price Target	23-02-02	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

7.36 USD

Average target price

13.33 USD

Spread / Average Target

+81.16%

High Price Target

17 USD

Spread / Highest target

+130.98%

Low Price Target

10 USD

Spread / Lowest Target

+35.87%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Accolade, Inc.

Wells Fargo Securities
Morgan Stanley
Stifel Nicolaus
Leerink Partners
Raymond James
Piper Sandler
Canaccord Genuity
Truist Securities
Credit Suisse
Needham & Co.
BofA Securities
DA Davidson
Guggenheim
Stephens Inc.
Jefferies & Co.
Berenberg Bank
Goldman Sachs
SVB Securities LLC
BTIG
SVB Leerink
Baird

Ratings for Accolade, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar